SENS Research Foundation's video: Genomics-based quality control for stem cell therapy: Parkinson s Disease - Jeanne Loring - RB2016

Scripps Research Institute Professor Jeanne Loring presented a summary of her lab’s efforts to employ human pluripotent stem cells as a therapy for incurable neurological disorders including Parkinson’s disease, multiple sclerosis and fragile X syndrome. Dr. Loring discusses the unpredictable but sometimes remarkable success of early fetal tissue transplants for Parkinson’s, and her optimism that sufficiently rigorous characterisation of the cell populations contributing to a positive outcome will lead within the next few years to a consistently curative therapy. This video was recorded at Rejuvenation Biotechnology 2016, a SENS Research Foundation conference held at the Buck Institute for Research on Aging on August 16-17, 2016. For more information, visit http://www.sens.org/rb2016